Asian Paints Subsidiaries Approve Amalgamation Scheme with Board Resolution

1 min read     Updated on 25 Mar 2026, 02:46 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Asian Paints' subsidiary companies have approved an amalgamation scheme where Nova Surface-Care Centre will merge with Harind Chemicals and Pharmaceuticals. The board approval was granted on March 24, 2026, with the transaction designed to streamline operations and reduce administrative costs while having no material financial impact on the parent company.

powered bylight_fuzz_icon
35916682

*this image is generated using AI for illustrative purposes only.

Asian Paints ' subsidiaries Harind Chemicals and Pharmaceuticals Private Limited and Nova Surface-Care Centre Private Limited have received board approval for their amalgamation scheme on March 24, 2026. The boards of both subsidiary companies approved the Scheme of Amalgamation with Nova as the Transferor Company and Harind as the Transferee Company, subject to regulatory approvals.

Board Approval and Regulatory Framework

The amalgamation was formally approved at the respective board meetings held on March 24, 2026. Asian Paints has informed stock exchanges BSE and NSE under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company emphasized that this scheme will not have any material impact on its financials.

Parameter: Details
Approval Date: March 24, 2026
Transferor Company: Nova Surface-Care Centre Private Limited
Transferee Company: Harind Chemicals and Pharmaceuticals Private Limited
Regulatory Status: Subject to Regulatory Approvals
Financial Impact: No Material Effect Expected

Company Structure and Financial Details

Nova Surface-Care Centre is a wholly-owned subsidiary of Harind Chemicals, while Asian Paints holds a 51% stake in Harind. Nova was incorporated on September 7, 2011, and Harind on June 6, 1995. The financial performance as of March 31, 2025, shows significant size differences between the entities.

Company: Net Worth (₹ crores) Turnover (₹ crores)
Nova Surface-Care Centre: 0.49 0.08
Harind Chemicals: 18.81 37.87

Business Operations and Strategic Rationale

Nova operates in testing services for paints and related chemicals, while Harind manufactures and deals in chemical products related to paints. The amalgamation rationale centers on operational efficiency, as Nova's laboratory capacity is exclusively used by Harind with minimal third-party commercial engagements.

The company stated that operating Nova as a separate entity is no longer strategically necessary. The amalgamation will streamline operations, reduce regulatory compliance multiplicity, generate administrative cost economies, and facilitate consolidated management.

Transaction Structure

The amalgamation involves no cash consideration as Harind holds Nova's entire share capital through itself and nominees. Upon scheme effectiveness, all Nova equity shares will be cancelled and extinguished. The transaction qualifies as a related party transaction conducted at arm's length in ordinary business course, with requisite Audit Committee approvals obtained.

Source: Company/INE021A01026/6892fa43-e94c-4cd6-b1af-4a0d8d15d8c0.pdf

Historical Stock Returns for Asian Paints

1 Day5 Days1 Month6 Months1 Year5 Years
-2.77%-2.42%-8.65%-8.18%-5.29%-8.11%

Will Asian Paints pursue similar consolidation strategies across its other subsidiary portfolio to achieve operational efficiencies?

How might the streamlined operations impact Asian Paints' competitive positioning in the chemical testing and manufacturing segment?

What timeline is expected for obtaining the necessary regulatory approvals for this amalgamation scheme?

Asian Paints Receives Mixed Analyst Ratings Amid Two-Phase Price Hike Strategy

1 min read     Updated on 24 Mar 2026, 09:16 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Asian Paints receives mixed analyst ratings as Morgan Stanley maintains underweight with Rs 2,126 target citing weak demand and competition, while Macquarie stays outperform at Rs 3,100. The company implements two-phase price hikes of 6-8% starting April 10 for core paints and April 21 for waterproofing, adhesives, and wood finishes. Rising competition from JSW-Akzo and higher market discounts are prompting industry-wide price increases, with Asian Paints boosting incentives to regain market share.

powered bylight_fuzz_icon
35869593

*this image is generated using AI for illustrative purposes only.

Asian Paints faces a divided analyst opinion as the paint manufacturer implements strategic price increases across its product portfolio. The company has announced a comprehensive two-phase pricing strategy amid challenging market conditions and intensifying competition.

Contrasting Analyst Perspectives

Two major investment firms have issued divergent views on Asian Paints' prospects following the company's pricing actions.

Analyst: Rating Target Price Stance
Morgan Stanley: Underweight Rs 2,126 Cautious
Macquarie: Outperform Rs 3,100 Optimistic

Two-Phase Price Hike Implementation

Asian Paints has structured its price increases in two distinct phases to address margin pressures:

Phase 1 (April 10):

  • 6-8% increase across core paints
  • Higher percentage hikes for thinners

Phase 2 (April 21):

  • 6-8% increase across waterproofing products
  • Price hikes for adhesives and wood finishes

Market Challenges and Competitive Dynamics

Morgan Stanley's cautious stance reflects several market headwinds facing the paint industry. The brokerage highlights weak retail-led paint demand as a primary concern, compounded by rising competition including aggressive moves from JSW-Akzo. Higher discounts in the market are prompting widespread price hikes across the industry, with Berger Paints already implementing 4-5% increases.

To counter competitive pressures, Asian Paints is reportedly boosting incentives to regain market share, indicating the intensity of the current market environment.

Margin Support Strategy

Macquarie takes a more optimistic view, emphasizing that the comprehensive price hikes across multiple product categories will support the company's margins. The brokerage's outperform rating with a significantly higher target price of Rs 3,100 suggests confidence in Asian Paints' ability to navigate current challenges and benefit from its pricing strategy.

The contrasting analyst views reflect the complex dynamics in the paint industry, where companies must balance competitive positioning with margin protection amid challenging demand conditions.

Historical Stock Returns for Asian Paints

1 Day5 Days1 Month6 Months1 Year5 Years
-2.77%-2.42%-8.65%-8.18%-5.29%-8.11%

How will JSW-Akzo's aggressive competitive moves impact Asian Paints' market share recovery efforts over the next 12 months?

What potential margin compression could Asian Paints face if competitors respond with deeper discounting to counter these price hikes?

Will the two-phase pricing strategy trigger similar structured price increases across other major paint manufacturers like Berger and Kansai Nerolac?

More News on Asian Paints

1 Year Returns:-5.29%